17 Jul 2019

Study links loss of ‘white matter’ in brain to MS symptom

Executive control includes the ability to stop ourselves from
behaving impulsively. The researchers have found that executive
control deficits are connected to reduced white matter in the
frontal lobe of the brain.
by Anne Crawford

While treatments are becoming increasingly effective in countering many of the symptoms of multiple sclerosis (MS), linking actual changes in the brain to its more elusive symptoms is vital to driving the development of therapies that can ultimately halt the disease.

Monash University researchers, led by Associate Professor Joanne Fielding and Dr Meaghan Clough in the Department of Neuroscience, are investigating deficits in executive control, that is the way our ‘higher brain’ controls basic behaviour, and determining which area in the brain is driving these deficits.

ACTA International Clinical Trials Conference

For those of you in forward planning mode, the ACTA International Clinical Trials Conference will be taking place this year from 2 - 5 October in Sydney.

The event, hosted by the Australian Clinical Trials Alliance, will be an opportunity to discuss global advances in the development of self-improving healthcare systems.

CCS Recent Publications 9th - 15th July

Recent publications for Central Clinical School feature affiliated authors in the following departments:
Dr Marcus Robinson was first author
on a paper involving numerous
researchers from our Immunology
and Pathology Department

  • MSHC
  • Peninsula Clinical School
  • ACBD
  • MAPrc
  • Infectious Diseases
  • Surgery
  • Immunology and Pathology
  • Gastroenterology

Related Posts Plugin for WordPress, Blogger...